Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 237 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2778 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CIPROFLOX 0.3% SOLUTION Resolved 2017-03-10 2019-06-12 110
APO-OFLOXACIN 0.3% SOLUTION Resolved 2017-03-10 2019-01-08 405
APO-TOBRAMYCIN 0.3% SOLUTION Actual shortage 2017-08-14 2017-10-05 19123
APO-GATIFLOXACIN 0.3% SOLUTION Resolved 2023-09-28 2023-11-24 205486
APO-GATIFLOXACIN 0.3% SOLUTION Resolved 2024-03-27 2024-04-12 223555
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Resolved 2017-03-10 2018-02-26 402
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-10 2017-05-13 9946
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-17 2017-10-24 15995
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-26 2017-11-13 17331
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-02 2021-02-23 123581
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-17 2021-02-23 124359
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-07 2021-02-23 125824
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973

Showing 101 to 120 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMOXI SUGAR FREE 125MG POWDER FOR SUSPENSION Discontinued 2018-09-07 2018-09-15 60249
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-SULIN TAB 150MG 150mg tablet Discontinued 2017-03-13 2017-03-13 1186
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-TEMAZEPAM 15MG CAPSULE Discontinued 2018-10-23 2019-01-14 65477
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316

Showing 121 to 140 of 356